tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
JonesResearch lists factors for Prime Medicine continued share rally
PremiumThe FlyJonesResearch lists factors for Prime Medicine continued share rally
19d ago
Hold Rating Issued for Verve Therapeutics Amid Eli Lilly Acquisition and Uncertain Milestones
Premium
Ratings
Hold Rating Issued for Verve Therapeutics Amid Eli Lilly Acquisition and Uncertain Milestones
30d ago
Verve Therapeutics downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
Verve Therapeutics downgraded to Market Perform from Outperform at BMO Capital
30d ago
Verve Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyVerve Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
Verve Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Verve Therapeutics downgraded to Hold from Buy at Jefferies
1M ago
Verve Therapeutics downgraded to Market Perform from Outperform at LifeSci
Premium
The Fly
Verve Therapeutics downgraded to Market Perform from Outperform at LifeSci
1M ago
Video: Verve, solar stocks among major pre-market movers
PremiumThe FlyVideo: Verve, solar stocks among major pre-market movers
1M ago
Verve Therapeutics Merges with Eli Lilly in Acquisition
Premium
Company Announcements
Verve Therapeutics Merges with Eli Lilly in Acquisition
1M ago
Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash
Premium
The Fly
Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100